PROCTER & GAMBLE HEALTH L vs ZYDUS LIFESCIENCES LTD
A side-by-side comparison of PROCTER & GAMBLE HEALTH L (PGHL) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
PROCTER & GAMBLE HEALTH L vs ZYDUS LIFESCIENCES LTD are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
- Valuation22
- Profitability40
- Growth02
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
PGHL takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
ZYDUSLIFE takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
ZYDUSLIFE takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has a good return on equity (ROE) track record: 3 Years ROE 42.6%", "Company has been maintaining a healthy dividend payout of 87.1%"]
- − ["Stock is trading at 17.9 times its book value", "The company has delivered a poor sales growth of 0.76% over past five years."]
- + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.